Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 197 publications
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Journal: Frontiers in oncology
Published: May 09, 2026
Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: March 25, 2026
Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.
Journal: Journal of the National Cancer Institute
Published: February 07, 2026
Identifying Patients With High-Risk Stage I NSCLC Using a Tumor-Informed Plasma ctDNA Assay.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 27, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.
Journal: Cancer research
Published: January 06, 2026
In Regard to Peters et al.
Journal: International journal of radiation oncology, biology, physics
Published: December 22, 2025
Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 10, 2025
Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.
Journal: The Laryngoscope
Published: November 03, 2025
Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.
Journal: Head & neck
Published: November 02, 2025
HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.
Journal: International journal of cancer
Published: October 27, 2025
Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [64Cu]Cu-DOTA-Panitumumab F(ab')2 and [177Lu]Lu-DOTA-Panitumumab F(ab')2.
Journal: Molecular pharmaceutics
Published: October 21, 2025
Time-dependent analysis of HUS change in older patients aged > 75 years with head and neck cancer.
Journal: Health and quality of life outcomes
Published: September 24, 2025
Last Updated: 09/26/2026